Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Endocare, Inc. was a medical device company renowned for its development and commercialization of innovative, minimally invasive cryoablation technologies. These technologies were primarily utilized for treating conditions such as prostate cancer, kidney cancer, and other urological issues, offering precise, targeted tissue destruction through extreme cold as an alternative to traditional surgery. Endocare's flagship Cryocare® system significantly advanced interventional oncology and urology. In 2014, Endocare, Inc. was acquired by HealthTronics, and its technologies continue to be part of HealthTronics' offerings.
The Irvine headquarters served as the primary center for Endocare's research and development, manufacturing operations for its cryoablation systems, global sales and marketing efforts, and corporate administration.
The facility would have included specialized R&D laboratories, potential clean-room manufacturing areas suitable for medical device production, and corporate office spaces designed to support a technology-focused company.
As a company in the medical technology sector, Endocare's work culture likely fostered innovation, precision engineering, strong collaboration between technical and medical teams, and a deep commitment to improving patient care and outcomes.
The Irvine headquarters was instrumental to Endocare's pioneering work in cryoablation technology, enabling the development and refinement of its systems and establishing its market presence as a leader in minimally invasive treatments.
Prior to its acquisition, Endocare, Inc. had a global reach, marketing and selling its cryoablation systems and associated products across the United States and internationally. Key markets included regions in Europe and Asia, where products were distributed through a mix of direct sales teams and specialized medical device distributors, enabling hospitals and clinics worldwide to utilize its advanced therapies.
201 Technology Drive
Irvine
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, EndoCare' leadership includes:
EndoCare has been backed by several prominent investors over the years, including:
Endocare, Inc. was acquired by HealthTronics in 2014 and no longer operates as an independent company. Therefore, there have been no executive new hires or exits attributable to 'Endocare' as a standalone entity in the last 12 months. Any leadership changes related to former Endocare technologies or operations would occur within HealthTronics or its parent company.
Discover the tools EndoCare uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its 2014 acquisition, Endocare, Inc. likely utilized common corporate email address formats. The domain 'endocare.com' is no longer active for company communications.
Speculative: [first_initial][last]@endocare.com (e.g., jdoe@endocare.com) or [first].[last]@endocare.com (e.g., jane.doe@endocare.com)
Format
jdoe@endocare.com
Example
0 (domain endocare.com is no longer actively used by the original company for email)%
Success rate
PR Newswire (on behalf of HealthTronics, Inc.) • August 5, 2014
HealthTronics, Inc. announced the successful completion of its acquisition of Endocare, Inc. (formerly NASDAQ: ENDC), a medical device company focused on the development of minimally invasive cryoablation technologies. This strategic acquisition aimed to enhance HealthTronics' portfolio in urology and interventional oncology....more
GlobeNewswire (Endocare, Inc. Press Release) • February 26, 2013
Endocare, Inc. (Nasdaq:ENDC) reported financial results for the fourth quarter and full year ended December 31, 2012, detailing revenues and operational performance prior to its acquisition by HealthTronics....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including EndoCare, are just a search away.